trial · primary record
NKT3964
Solid Tumor
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 238 |
| Primary completion | 2029-05 |
| Primary endpoint | Number of Participants with Dose Limiting Toxicity (DLT) events |
| Registry ID | NCT06586957 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:44:14.924Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06586957
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.